Source:http://linkedlifedata.com/resource/pubmed/id/18369313
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4 Pt 1
|
| pubmed:dateCreated |
2008-8-13
|
| pubmed:abstractText |
First, to identify treatment satisfaction thresholds for interpreting treatment-related changes in vasomotor symptoms, and, second, to determine the doses of desvenlafaxine (DVS) (administered as desvenlafaxine succinate) that effectively provide relief of vasomotor symptoms considered important by menopausal women.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1072-3714
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
15
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
698-705
|
| pubmed:meshHeading |
pubmed-meshheading:18369313-Cyclohexanols,
pubmed-meshheading:18369313-Double-Blind Method,
pubmed-meshheading:18369313-Female,
pubmed-meshheading:18369313-Hot Flashes,
pubmed-meshheading:18369313-Humans,
pubmed-meshheading:18369313-Menopause,
pubmed-meshheading:18369313-Middle Aged,
pubmed-meshheading:18369313-Neurotransmitter Uptake Inhibitors,
pubmed-meshheading:18369313-Patient Satisfaction
|
| pubmed:articleTitle |
Identifying meaningful differences in vasomotor symptoms among menopausal women.
|
| pubmed:affiliation |
Saint Louis University, 3750 Lindell Boulevard, Suite 230, McGannon Hall, St. Louis, MO 63108, USA. wyrwichk@slu.edu
|
| pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|